Frequency of vaccine-related reactogenicity events and other adverse events Throughout study [clinicaltrials_resource:a535046a16980ebb392763d8b8347d11]
Participants will receive one dose of vaccine virus at study entry and between Weeks 22 and 27
clinicaltrials_vocabulary:primary outcome [clinicaltrials_vocabulary:clinicaltrials_vocabulary:primary-outcome]
Frequency of vaccine-related reactogenicity events and other adverse events Throughout study [clinicaltrials_resource:a535046a16980ebb392763d8b8347d11]
Participants will receive one dose of vaccine virus at study entry and between Weeks 22 and 27
Bio2RDF identifier
a535046a16980ebb392763d8b8347d11
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:a535046a16980ebb392763d8b8347d11
measure [clinicaltrials_vocabulary:measure]
Frequency of vaccine-related reactogenicity events and other adverse events
time frame [clinicaltrials_vocabulary:time-frame]
Throughout study
description
Participants will receive one ...... ry and between Weeks 22 and 27
identifier
clinicaltrials_resource:a535046a16980ebb392763d8b8347d11
title
Frequency of vaccine-related r ...... dverse events Throughout study
@en
type
label
Frequency of vaccine-related r ...... 5046a16980ebb392763d8b8347d11]
@en